Search
for
Sort by
Research 751–780 of 1000+
- Sebaceous Gland Regeneration in Human Skin Xenografts
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts
- Diagnostic Exercise: Severe Bilaterally Symmetrical Alopecia in a Horse
- Finasteride-related Leydig cell tumour: report of a case and literature review
- Novel causes of drug-induced occupational asthma
- ADRENAL ONCOCYTOMA IN CHILDREN – case report
- Management of autoimmune associated alopecia areata
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- Management of autoimmune associated alopecia areata
- Secondary Cicatricial Scalp Alopecia Caused by Brunsting-Perry Pemphigoid: A Case Report
- Canine alopecia X-Like disorder
- Giant solitary trichoepithelioma: A rare trichogenic tumor
- Canine alopecia X-Like disorder
- Facial Follicular Spicules: A Rare Cutaneous Presentation of Trichodysplasia Spinulosa
- Folliculotropic mycosis fungoides
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Toxic epidermal necrolysis due to cephalexin
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Prevalence and treatment approach of canine Demodicosis
- 28th Turkish National Dermatology Congress, September 24–28, 2019, Antalya, Turkey
- Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation
- Alopecia Following Deoxycholic Acid Treatment for Submental Adiposity
- Follicular mucinosis in association with Sezary syndrome
- Diffuse Alopecia in a Hemodialysis Patient Caused by a Low-Molecular-Weight Heparin, Tinzaparin
- Successful induction of oral tolerance in Netherton syndrome
- Solitary fixed drug eruption caused by finasteride
- Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction